Table 1 Characteristics of patients and controls
TNF | NBS | |||
|---|---|---|---|---|
N | 6256 | 13,241 | ||
Women, % | 61.6 | 60.5 | ||
Age mean (SD) | 52.0 | (14.5) | 56.1 | (16.3) |
Women | 53.1 | (14.5) | 56.0 | (16.6) |
Men | 50.3 | (14.3) | 56.3 | (15.8) |
Antidepressants | ||||
Baseline rate, % | 11.8 | 10.9 | ||
Controls, % | 6.6 | 7.6 | ||
Difference (95% c.i.) | 5.2 | (4.35–5.99) | 3.3 | (2.77–3.87) |
Benzodiazepine-related hypnotics | ||||
Baseline rate, % | 10.7 | 10.4 | ||
Controls, % | 6.6 | 7.6 | ||
Difference (95% c.i.) | 4.1 | 3.34–4.92 | 2.8 | 2.25–3.33 |
Number of drugs (substances, 3 months before index) | ||||
Patients | ||||
mean (SD) | 6.9 | (4.2) | 6.5 | (3.8) |
Controls | ||||
mean (SD) | 2.0 | (3.0) | 2.3 | (3.1) |
Number of outpatient visits (past 12 months) | ||||
Patients | ||||
mean (SD) | 5.6 | (4.1) | 3.0 | (3.7) |
Controls | ||||
mean (SD) | 0.8 | (2.3) | 0.8 | (2.4) |
Proportion, at least one hospitalization (past 12 months) | ||||
Patients, % | 20 | 21 | ||
Controls, % | 9 | 10 | ||